US Iodine Market Analysis, Size, and Forecast 2026-2030

US Iodine Market Size 2026-2030

The us iodine market size is valued to increase by USD 61.9 million, at a CAGR of 4.5% from 2025 to 2030. Expansion of diagnostic imaging and high-fidelity radiography standards will drive the us iodine market.

Major Market Trends & Insights

• By Source - Underground brine segment was valued at USD 139.1 million in 2024
• By Form Factor - Organic compounds segment accounted for the largest market revenue share in 2024

Market Size & Forecast

• Market Opportunities: USD 105.5 million
• Market Future Opportunities: USD 61.9 million
• CAGR from 2025 to 2030 : 4.5%

Market Summary

• The iodine market in us is defined by its critical role in high-value sectors, particularly healthcare and specialty chemicals. Market dynamics are shaped by the persistent demand for x-ray contrast agents used in diagnostic imaging, a need that intensifies with an aging population and the rising prevalence of chronic conditions.
• Concurrently, the industry is navigating a strategic shift toward bolstering domestic production capabilities, primarily through underground brine extraction, to reduce reliance on a concentrated global supply chain. This move toward resource security is a direct response to geopolitical uncertainties and logistical bottlenecks that can impact availability and pricing.
• For instance, a manufacturer of radiopharmaceuticals must secure a consistent supply of high-purity iodine isotopes; any disruption directly threatens their ability to produce life-saving diagnostic and therapeutic agents. This operational dependency underscores the market-wide emphasis on developing resilient supply chains, investing in advanced ion-exchange technology, and exploring iodine recycling initiatives to create a more stable and self-sufficient ecosystem.

What will be the Size of the US Iodine Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the US Iodine Market Segmented?

The us iodine industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2026-2030, as well as historical data from 2020-2024 for the following segments.

By Source Insights

The underground brine segment is estimated to witness significant growth during the forecast period.

Request Free Sample

The Underground brine segment was valued at USD 139.1 million in 2024 and showed a gradual increase during the forecast period.

Request Free Sample

Market Dynamics

Our researchers analyzed the data with 2025 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

• The iodine market in us 2026-2030 is experiencing significant evolution, driven by its indispensable role in advanced applications. The primary iodine use in x-ray contrast agents continues to anchor demand, as medical imaging requires high-purity compounds for diagnostic clarity.
• Concurrently, the function of povidone-iodine as a topical antiseptic remains a stable pillar in healthcare, essential for infection control in clinical and surgical settings. Beyond medicine, the iodine role in lcd polarizing films is critical for the electronics industry, where it enables the functionality of modern displays.
• A less visible but vital application is in the creation of iodine derivatives for pharmaceutical synthesis, where they act as key intermediates in manufacturing a range of active pharmaceutical ingredients. The foundational supply for these diverse applications increasingly comes from underground brine as an iodine source.
• This domestic extraction method offers a more secure supply chain compared to international sources, with some advanced facilities demonstrating a production consistency that is 15% higher than older, less efficient processing methods. This shift ensures a reliable feedstock for all key end-use segments.

What are the key market drivers leading to the rise in the adoption of US Iodine Industry?

• The primary market driver is the expansion of diagnostic imaging procedures and increasingly stringent standards for high-fidelity radiography, which elevates demand for iodinated contrast agents.

• Demand is primarily driven by the healthcare sector's reliance on iodine for advanced medical applications.
• The increasing use of iodinated contrast media in diagnostic imaging is a fundamental growth catalyst, as these materials are essential for producing clear x-ray contrast agents.
• The market for pharmaceutical grade iodine is expanding due to its role in synthesizing organic iodine compounds and critical radiopharmaceuticals for nuclear medicine isotopes.
• Innovations in radiopaque materials science are leading to safer and more effective products, with some new formulations reducing patient adverse reaction rates by up to 25%. Furthermore, the use of povidone-iodine remains a standard in clinical settings.
• The indispensable role of iodine in thyroid hormone synthesis also ensures steady demand from the pharmaceutical industry, making healthcare a consistent and powerful driver of market activity.

What are the market trends shaping the US Iodine Industry?

• A pronounced trend is the accelerated vertical integration within domestic brine extraction operations, driven by the strategic imperative to enhance supply chain autonomy.

• A key trend shaping the market is the convergence of advanced production and recycling technologies. The adoption of ion-exchange technology is enhancing domestic output, while emerging iodine recycling initiatives promise to create a circular economy for this critical element.
• This dual approach helps mitigate iodine price volatility, which is a significant concern for manufacturers of optical polarizing films and low-osmolar contrast agents. Investments in iodinated polymer manufacturing are growing, driven by demand from the electronics sector. In parallel, contrast media formulation is evolving to improve patient outcomes, with research focused on bioavailability.
• This drive for efficiency is evident as new domestic plants achieve operational uptimes 15% greater than legacy facilities. This progress ensures a stable supply for both industrial uses, like iodine for electronics, and essential products, such as animal nutrition additives.

What challenges does the US Iodine Industry face during its growth?

• A critical challenge stems from severe supply chain concentration and a significant dependency on geopolitical imports, creating strategic vulnerabilities for domestic consumption.

• The market contends with significant challenges related to supply chain stability and regulatory compliance. The reliance on a limited number of international sources for high-purity chemical feedstock creates vulnerabilities, impacting the production of fluorochemicals and specialty chemicals feedstock. This concentration risk is a primary concern for downstream industries. Domestically, operators face complex requirements for managing industrial catalysts and iodine isotopes.
• The formulation of biocidal products, including antiseptic solutions, is governed by stringent efficacy and safety standards, where non-compliance can lead to recalls costing millions. For instance, improving biocidal formulation chemistry to meet new environmental standards can increase R&D costs by 30%.
• The inherent properties of iodophor disinfectant properties require careful handling and disposal protocols, adding another layer of operational complexity and cost for manufacturers.

Exclusive Technavio Analysis on Customer Landscape

The us iodine market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the us iodine market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape of US Iodine Industry

Competitive Landscape

Companies are implementing various strategies, such as strategic alliances, us iodine market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

AGC Inc. - Analysis indicates a focus on high-purity iodine derivatives for pharmaceutical, electronics, and industrial sectors, supported by a global supply infrastructure.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• AGC Inc.
• Ajay Europe SARL
• Algorta Norte SA
• American Elements Inc.
• Calibre Chemicals Pvt.
• Deepwater Chemicals.
• Hemera Pharma S.r.l.
• Iochem Corp.
• Iofina plc
• K and O Iodine Co. Ltd.
• KIVA Holding, Inc.
• Nippoh Chemicals Co.
• Nippon Chemical Industrial Co.
• Spectrum Chemical Mfg. Corp.
• SQM S.A.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Us iodine market

• In September 2024, Iofina plc announced the successful commissioning of its ninth IOsorb plant in Western Oklahoma, expanding its domestic production capacity of crystalline iodine by an estimated 100 metric tonnes annually to meet growing demand from the pharmaceutical sector.
• In November 2024, the US Department of Commerce, in partnership with key industry stakeholders, launched an initiative to map and secure domestic supply chains for critical minerals, including iodine, to mitigate geopolitical import dependency and price volatility.
• In February 2025, GE HealthCare received FDA approval for a new low-osmolar iodinated contrast media, developed to enhance imaging clarity in CT angiography while improving patient safety profiles, with manufacturing slated to begin at its US facilities.
• In April 2025, SQM S.A. completed a strategic investment of $50 million to upgrade its logistics and distribution hubs in North America, aiming to reduce lead times for iodine and its derivatives to key industrial and medical customers by over 20%.

Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled US Iodine Market insights. See full methodology.

Request Free Sample

Research Analyst Overview

• The iodine market in us is undergoing a strategic realignment focused on enhancing domestic resource security and technological self-sufficiency. The expansion of underground brine extraction, utilizing advanced ion-exchange technology and existing saltwater disposal infrastructure, is pivotal to this shift. This focus allows for the consistent production of crystalline iodine and elemental iodine, which are essential for high-value downstream applications.
• The market is heavily influenced by the demand for medical-grade iodine, particularly for iodinated contrast media and povidone-iodine antiseptic solutions. Additionally, high-purity iodine derivatives are critical for manufacturing optical polarizing films and enabling complex specialty chemical synthesis.
• To meet stringent quality standards, producers are investing in processes that deliver a purity level 10% higher than the industry average of five years ago. This commitment to quality ensures a reliable supply for x-ray contrast agents, radiopharmaceuticals, and other critical end-uses, mitigating risks associated with import reliance.

What are the Key Data Covered in this US Iodine Market Research and Growth Report?

• What is the expected growth of the US Iodine Market between 2026 and 2030?

  • USD 61.9 million, at a CAGR of 4.5%

• What segmentation does the market report cover?

  • The report is segmented by Source (Underground brine, and Caliche ore), Form Factor (Organic compounds, Inorganic salts and complexes, and Elementals and isotopes), Application (Medical, Optical polarizing films, Fluorochemicals, Biocides, and Others) and Geography (North America)

• Which regions are analyzed in the report?

  • North America

• What are the key growth drivers and market challenges?

  • Expansion of diagnostic imaging and high-fidelity radiography standards, Severe supply chain concentration and geopolitical import dependency

• Who are the major players in the US Iodine Market?

  • AGC Inc., Ajay Europe SARL, Algorta Norte SA, American Elements Inc., Calibre Chemicals Pvt., Deepwater Chemicals., Hemera Pharma S.r.l., Iochem Corp., Iofina plc, K and O Iodine Co. Ltd., KIVA Holding, Inc., Nippoh Chemicals Co., Nippon Chemical Industrial Co., Spectrum Chemical Mfg. Corp. and SQM S.A.

Market Research Insights

• The market is advancing through the strategic adoption of sophisticated technologies and processes. The implementation of advanced purification techniques in domestic iodine production has enabled a 20% increase in yield for pharmaceutical grade iodine. Concurrently, the development of sustainable extraction methods is reducing the environmental impact of extraction, with new facilities demonstrating a lower carbon footprint.
• This focus on domestic supply chain security is crucial for sectors dependent on iodine derivatives applications. Innovations in iodine recycling technology are also gaining traction, offering the potential to recapture up to 30% of iodine from industrial waste streams. These advancements collectively address iodine price volatility and support the consistent manufacturing of high-purity chemical feedstock and other critical materials.

We can help! Our analysts can customize this us iodine market research report to meet your requirements.

Get in touch